glp-1 drug market news today Drugs Drop More Than Just Weight GLP-1 Receptor Agonist Market Size

By injecting Mounjaro, which combines the effects of both GIP and GLP, it is expected to affect the satiety center and suppress appetite

Current research is examining whether GLP-1 therapy can modify the trajectory of autoimmune diseases by addressing the metabolic dysfunction that amplifies immune dysregulation

At TIXiMED, we are excited to share new peer-reviewed data on #TIX100, published in Diabetes, Obesity and Metabolism by investigators at the UAB Comprehensive Diabetes Center

As of 2024, researchers estimated that about 12% or one in every eight adult Americans had ever taken a GLP-1 medication

A new study presented at the 2025 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) examined how the timing of a patients last dose of Ozempic prior to total knee arthroplasty (TKA) or total hip arthroplasty (THA) influences anesthesia-related complications such as delayed emergence, aspiration, aspiration pneumonitis and conversion to intubation

For example, some salad menus offer half size or full size. Or consider offering ways for a group of diners to all split one entre for an extra fee